Is 0DHA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0DHA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0DHA (NOK144.6) is trading above our estimate of fair value (NOK61.45)
Significantly Below Fair Value: 0DHA is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0DHA?
Key metric: As 0DHA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for 0DHA. This is calculated by dividing 0DHA's market cap by their current
earnings.
What is 0DHA's PE Ratio?
PE Ratio
32.7x
Earnings
NOK 242.59m
Market Cap
NOK 7.94b
0DHA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: 0DHA is expensive based on its Price-To-Earnings Ratio (32.7x) compared to the European Industrials industry average (16.8x).
Price to Earnings Ratio vs Fair Ratio
What is 0DHA's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
0DHA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
32.7x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 0DHA's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.